Transarterial Chemoembolization Market: How Is Drug-Eluting Bead TACE Improving Treatment Delivery?
Drug-eluting bead technology represents the major technical evolution from conventional TACE, with the Transarterial Chemoembolization Market reflecting the commercial adoption of DEB-TACE products from Biocompatibles (DC Bead), BTG, and competitive platforms providing controlled drug release from embolizing microspheres that conventional lipiodol-based TACE's uncontrolled drug release cannot...
0 Σχόλια 0 Μοιράστηκε 191 Views 0 Προεπισκόπηση